NEWS

Seal Rock Therapeutics Presents Data Highlighting Superior Efficacy of ASK1 Inhibitor, SRT-015, to Selonsertib for NASH

Nov 16, 2020 |

Read More |

Download PDF

FINAL Sealrock AASLD press release 11_16

Seal Rock Therapeutics Announces Upcoming Presentations at AASLD’s The Liver Meeting® 2020

Nov 2, 2020 |

Read More |

Download PDF

Nov 2 2020 Seal Rock Therapeutics Releas

Seal Rock Therapeutics Advancing Differentiated ASK1 Inhibitor Lead Candidate SRT-015 in NASH

Nov 9, 2018 |

Read More |

Download PDF

Nov 9 2018 Seal Rock Therapeutics Releas